ATXS (Astria Therapeutics Inc) Sof foyda

ATXS (Astria Therapeutics, Inc.) - kompaniyaning tovar belgisi

GURU.Markets platformasidagi Astria Therapeutics (ATXS) kompaniyasining daromadlar tarixi grafigi hozirda -0.13 darajasida turibdi. Biznes murakkab biomolekulalarni tibbiyot markazlariga tashish paytida qat'iy harorat nazoratiga tayanadi. Astria Therapeutics (ATXS) qimmat R&D xarajatlari va yangi ishtirokchilarning bozorga kirishini cheklaydigan kamyob dori vositalarining patent himoyasi kabi qiyinchiliklarni yengib o'tgan holda, organizmning himoya tizimini mustahkamlovchi agentlarni ishlab chiqadi.

ATXS (Astria Therapeutics) Sof foyda tarixi 04.07.2022dan 07.02.2026gacha

Astria Therapeutics, Inc. (ATXS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Astria Corp|ATXS - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Astria Corp|ATXS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Astria Therapeutics|ATXS - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi astriatx.com|ATXS - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Astria Therapeutics|ATXS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Astria Therapeutics Inc|ATXS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Astria Corp|ATXS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Astria Therapeutics|Shoshilinch likvidlik astriatx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ATXS - Sof foyda
Kompaniyaning jamlanma tahlili:Astria Therapeutics
Astria Pharma asosiy tovari

Astria Therapeutics (ATXS) kam uchraydigan immun patologiyalari uchun innovatsion terapiyalarni ishlab chiqadi. Kompaniyaning moliyaviy natijalarini tahlil qilib, investor kunlik sof daromad dinamikasini kuzatishi mumkin. Ushbu ko'rsatkich fundamental tendentsiyani tasodifiy bozor shovqinlaridan ajratib, biznesning haqiqiy barqarorligini aks ettiradi. Tijoratdan oldingi sektor uchun ushbu metrika tijoratlashtirishdan oldingi mablag'lar sarf-xarajatlar darajasini (burn rate) ifodalaydi. Ushbu ko'rsatkichlarning barqaror o'sishi defolt xavfini minimallashtiradi va strategiyaning hayotiy ekanligini tasdiqlaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|UPB - Sof moliyaviy natija|Sof daromad ZBIO|IMNM (Immunome Inc) - Soliqlar to‘langandan keyingi foyda|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|KALV (KalVista Corp) - Yakuniy foyda|Sof foyda SEPN (Septerna Inc)|Sof moliyaviy natija pieris.com (PVLA)|Savara - Sof foyda|RIGL - Sof foyda|ANAB (AnaptysBio Corp) - Sof daromad|enGene Corp - Yakuniy foyda|Sof daromad RAPT|JBIO (Aerovate) - Soliqlar to‘langandan keyingi foyda|Sof foyda ACRS|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Sof foyda TLSA (Tiziana Life Sciences PLC)|Cabaletta Bio Inc (CABA) - Kompaniyaning sof daromadi|VTYX - Kompaniyaning sof foydasi|Yakuniy foyda THTX (theratech.com)|AVTX: Sof foyda|Eledon Pharmaceuticals Inc. (ELDN) - Sof foyda|Kompaniyaning sof foydasi Agenus Inc|Climb Bio, Inc - Soliqdan keyingi foyda|Sof foyda ZURA|ATYR - Kompaniyaning sof daromadi|Adagene Inc. - Sof daromad|Sof foyda ImageneBio IMA|STTK: Sof daromad|Equillium, Inc. - Soliqlar to‘langandan keyingi foyda|CNTB: Sof foyda|IMUX - Sof moliyaviy natija|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|Sof daromad InflaRx GmbH (IFRX)|Kompaniyaning sof foydasi X4 Pharma (XFOR)|Sof moliyaviy natija adicetbio.com|Sof foyda CELU (Celularity)|Sof foyda inmunebio.com INMB|BRNS: Sof daromad|Kezar Life Sciences Inc. - Soliqlar to‘langandan keyingi foyda|SABS (SAB Biotherapeutics, Inc) - Sof daromad|Kompaniya foydasi AKTX|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Q32 Bio Corp (QTTB) - Sof moliyaviy natija|Kompaniyaning sof foydasi GeoVax (GOVX)|EDSA: Soliqdan keyingi foyda|Sof foyda IBIO (iBio Corp)|Yakuniy foyda CARM|XTL Biopharmaceuticals - Sof foyda|BOLT - Sof foyda|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Aptevo Therapeutics Inc. - Yakuniy foyda|Kompaniyaning sof foydasi AIM ImmunoTech|Sof daromad Aditxt Corp (ADTX)|Sof foyda GRI|Sof foyda xortx.com (XRTX)|Vyome Holdings - Sof daromad|Yakuniy foyda REVB|Indaptus - Sof foyda|Sof moliyaviy natija BiondVax Pharmaceuticals SCNI|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Sof daromad IGMS (IGM Biosciences, Inc.)|Sof foyda iTeos Pharma (ITOS)|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP: Kompaniya foydasi|Third Harmonic Bio, Inc. - Sof foyda